Full Fed Circ. Asked To Review Ensnarement In $200M IP Suit
By Steven Trader ( October 31, 2017, 6:58 PM EDT) -- The cardiologist who lost a contract suit seeking $200 million in royalties from Boston Scientific on his stent patents told the Federal Circuit in an en banc rehearing motion Monday that the company's use of the rare ensnarement defense "was the height of unfair surprise" and should have been disallowed....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.